KP Tissue Inc
TSX:KPT

Watchlist Manager
KP Tissue Inc Logo
KP Tissue Inc
TSX:KPT
Watchlist
Price: 8.92 CAD -1.11% Market Closed
Market Cap: 89.2m CAD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of KPT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KPT Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
1
Forward
0
More Details
29.2
P/E
P/E
Price to Earnings
29.2
vs History
22
vs Industry
40
Median 3Y
-4.7
Median 5Y
-6.4
Industry
17.3
Forward
23.2
More Details
N/A
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
11.9
More Details
N/A
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
17
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
33
vs Industry
52
Median 3Y
1.2
Median 5Y
1.2
Industry
1.5
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
1.2
Forward
0
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
3.9
More Details
N/A
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
Forward
0.3
More Details
N/A
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
13
Forward
0.5
More Details
N/A
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
12.6
More Details
N/A
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
15.3
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
23
vs Industry
42
Median 3Y
1.2
Median 5Y
1.2
Industry
1.2
More Details

Multiples Across Competitors

KPT Competitors Multiples
KP Tissue Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
KP Tissue Inc
TSX:KPT
89.1m CAD 0 29.2 0 0
US
Procter & Gamble Co
NYSE:PG
367.9B USD 4.4 24.2 16.5 18.8
US
Colgate-Palmolive Co
NYSE:CL
74.1B USD 3.7 25.6 16.1 18.3
UK
Reckitt Benckiser Group PLC
LSE:RKT
34.5B GBP 2.4 24.2 8.7 12.1
US
Kimberly-Clark Corp
NYSE:KMB
43.6B USD 2.2 17.7 11 13.3
DE
Henkel AG & Co KGaA
XETRA:HEN3
28.5B EUR 1.3 21.6 8.2 11.2
US
Church & Dwight Co Inc
NYSE:CHD
24.2B USD 4 41.9 24.4 31.7
SE
Essity AB (publ)
STO:ESSITY B
184.2B SEK 1.3 14.7 7.9 10.9
US
Clorox Co
NYSE:CLX
15.5B USD 2.2 22.3 13.9 16.7
JP
Unicharm Corp
TSE:8113
1.8T JPY 1.9 20.7 8.3 11.3
MX
Kimberly-Clark de Mexico SAB de CV
BMV:KIMBERA
104.1B MXN 1.9 13.7 7.9 9.2

See Also

Summary
KPT intrinsic value, competitors valuation, and company profile.
DCF Valuation
KPT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KPT stock valuation using valuation multiples.
Wall Street Estimates
KPT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KPT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 266,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.